Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula Berman

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Cancers|September 3, 2020
Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical OutcomeGil Bar-Sela, Idan Cohen, Salvatore Campisi-Pinto, et al.
Cancers|April 23, 2022
Correction: Bar-Sela et al. Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome. <i>Cancers</i> 2020, <i>12</i>, 2447Gil Bar-Sela, Idan Cohen, Salvatore Campisi-Pinto, et al.
Molecular Plant|June 5, 2024
The biosynthetic pathway of the hallucinogen mescaline and its heterologous reconstructionPaula Berman, Luis Alejandro de Haro, Ana-Rita Cavaco, et al.
Science Advances|April 1, 2026
Complete biosynthesis of psychedelic tryptamines from three kingdoms in plantsPaula Berman, Janka Höfer, Herschel Mehlman, et al.
Nature Plants|May 1, 2023
Parallel evolution of cannabinoid biosynthesisPaula Berman, Luis Alejandro de Haro, Adam Jozwiak, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Cancers|September 3, 2020
Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical OutcomeGil Bar-Sela, Idan Cohen, Salvatore Campisi-Pinto, et al.
Cancers|April 23, 2022
Correction: Bar-Sela et al. Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome. <i>Cancers</i> 2020, <i>12</i>, 2447Gil Bar-Sela, Idan Cohen, Salvatore Campisi-Pinto, et al.
Molecular Plant|June 5, 2024
The biosynthetic pathway of the hallucinogen mescaline and its heterologous reconstructionPaula Berman, Luis Alejandro de Haro, Ana-Rita Cavaco, et al.
Science Advances|April 1, 2026
Complete biosynthesis of psychedelic tryptamines from three kingdoms in plantsPaula Berman, Janka Höfer, Herschel Mehlman, et al.
Nature Plants|May 1, 2023
Parallel evolution of cannabinoid biosynthesisPaula Berman, Luis Alejandro de Haro, Adam Jozwiak, et al.
Pageof 3